Back
PTC Therapeutics Stock Price Chart
Sponsored
PTCT
Sponsored
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject
Sell
35
PTCT
PTC Therapeutics
Last Price:
30.99
Seasonality Move:
8.11%
7 Day Trial
ALL ACCESS PASS
$
7
Buy a stock when it crosses this line on the chart
Here's the line to follow.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.97 | Sell |
20-day SMA: | 35.08 | Sell |
50-day SMA: | 34.11 | Sell |
200-day SMA: | 27.6 | Buy |
8-day EMA: | 32.46 | Sell |
20-day EMA: | 34.04 | Sell |
50-day EMA: | 33.6 | Sell |
200-day EMA: | 31.79 | Sell |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 38.05 | Sell |
Chaikin Money Flow: | 242921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.07 - 37.67) | Sell |
Bollinger Bands (100): | (26.88 - 35.22) | Sell |
PTC Therapeutics Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 31.00 while PTCT 8-day simple moving average is 32.97, which is a Sell signal.
- The stock price of PTCT is 31.00 while PTC Therapeutics 20-day SMA is 35.08, which makes it a Sell.
- PTC Therapeutics 50-day simple moving average is 34.11 while PTCT share price is 31.00, making it a Sell technically.
- PTCT stock price is 31.00 and PTC Therapeutics 200-day simple moving average is 27.60, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Sell
35
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a Sell
The current PTC Therapeutics [PTCT] share price is $31.00. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
PTC Therapeutics Stock Info
Market Cap:
2.38B
Price in USD:
31.00
Share Volume:
362.25K
PTC Therapeutics 52-Week Range
52-Week High:
42.63
52-Week Low:
17.53
Sell
35
PTC Therapeutics (PTCT)
is a Sell
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?
The PTC Therapeutics stock price is 31.00 USD today. -
Will PTCT stock go up or go down?
PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is PTC Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is overvalued.
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 31.00 while PTCT 8-day exponential moving average is 32.46, which is a Sell signal.
- The stock price of PTCT is 31.00 while PTC Therapeutics 20-day EMA is 34.04, which makes it a Sell.
- PTC Therapeutics 50-day exponential moving average is 33.60 while PTCT share price is 31.00, making it a Sell technically.
- PTCT stock price is 31.00 and PTC Therapeutics 200-day simple moving average is 31.79, creating a Sell signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
- PTCT Moving Average Covergence Divergence (MACD) indicator is -0.95, suggesting PTC Therapeutics is a Sell
- PTC Therapeutics Relative Strength Index (RSI) is 38.05, which suggest PTC Therapeutics is oversold
- The Bollinger Bands (25) for PTC Therapeutics is (33.07 - 37.67), which suggest PTC Therapeutics is a Sell
- The Bollinger Bands (100) for PTC Therapeutics is (26.88 - 35.22), which suggest PTC Therapeutics is a Sell
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.